KALA BIO, Inc.
KALA
$9.31
$0.536.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.09% | 9.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.13% | 12.57% | |||
| Operating Income | -2.13% | -12.57% | |||
| Income Before Tax | -24.68% | -9.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -24.68% | -9.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.68% | -9.44% | |||
| EBIT | -2.13% | -12.57% | |||
| EBITDA | -2.16% | -12.67% | |||
| EPS Basic | -21.48% | 19.04% | |||
| Normalized Basic EPS | -20.10% | 19.22% | |||
| EPS Diluted | -21.48% | 19.04% | |||
| Normalized Diluted EPS | -20.10% | 19.22% | |||
| Average Basic Shares Outstanding | 2.63% | 35.17% | |||
| Average Diluted Shares Outstanding | 2.63% | 35.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||